{"id":881719,"date":"2025-09-03T16:32:07","date_gmt":"2025-09-03T20:32:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-launches-sleep-institute-to-elevate-sleep-health-as-a-global-priority\/"},"modified":"2025-09-03T16:32:07","modified_gmt":"2025-09-03T20:32:07","slug":"resmed-launches-sleep-institute-to-elevate-sleep-health-as-a-global-priority","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/resmed-launches-sleep-institute-to-elevate-sleep-health-as-a-global-priority\/","title":{"rendered":"Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority"},"content":{"rendered":"

\nNew global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health care
\n<\/h2>\n
\n

SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the launch of Sleep Institute<\/a>, a global clinical insights initiative dedicated to advancing the science and understanding of sleep health.<\/p>\n

Sleep Institute partners with clinicians, researchers, policymakers, and health system leaders to deliver objective, non-commercial, evidence-based insights that help inform care innovation, support policy decisions, and elevate sleep as a global health priority. The announcement comes ahead of the World Sleep Congress<\/a>, taking place September 5\u201310 in Singapore.<\/p>\n

Sleep disorders are among the most common health challenges worldwide, with an estimated 1 billion people living with obstructive sleep apnea (OSA)1<\/sup> and about 852 million adults experiencing clinically relevant insomnia2<\/sup>. Yet, the majority of people remain undiagnosed, fueling higher rates of chronic disease, lost productivity, and rising healthcare costs3<\/sup>. To help address this gap, Sleep Institute publishes original research, expert perspectives, and real-world data to support earlier and more accurate diagnosis and guide more informed clinical, policy, and system-level strategies.<\/p>\n

\u201cSleep Institute reflects Resmed\u2019s commitment to advancing sleep health worldwide,\u201d said Kimberly L. Sterling, vice president, health research at Resmed, on behalf of Sleep Institute. \u201cIt\u2019s about moving from awareness to action \u2014 giving global health and policy leaders the insights they need to close today\u2019s care gaps and shape tomorrow\u2019s sleep medicine.\u201d<\/p>\n

New findings from a U.S. consumer survey conducted by Sleep Institute4<\/sup> highlight this need. While more than four in five respondents said sleep is important to their overall health, only one in three reported that a doctor or nurse has asked them about their sleep in the past six months. This disconnect illustrates the need to better integrate sleep into routine healthcare and policy discussions, a central focus of Sleep Institute\u2019s work.<\/p>\n

\n Global Collaboration at World Sleep Congress<\/strong>\n <\/p>\n

Sleep Institute will debut at the World Sleep Congress, with an expert led symposium tackling one of sleep medicine\u2019s most pressing challenges: the global underdiagnosis of OSA. The session will examine barriers in diagnostic pathways for OSA and highlight scalable solutions to help improve access and outcomes.<\/p>\n

The symposium, OSA Underdiagnosis \u2013 A world of difference, a common challenge<\/em>, brings together clinical leaders from Iceland, Singapore, the United States, and Sweden, including:<\/p>\n